TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.60$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Investor relations

Report Dates

Investor relations overview for Neuraxis, Inc. (NRXS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/11/2026
Earnings surprise by quarter (%)
Q3 23 · -694.1 % 23 Q4 23 · -69.8 % 23 Q1 24 · -220.0 % 24 Q2 24 · -743.2 % 24 Q4 24 · -612.5 % 24 Q1 25 · -37.5 % 25 Q2 25 · -15.8 % 25 Q3 25 · -20.0 % 25 Q4 25 · 52.4 % 25 Q1 26 · 25.8 % 26 Q2 26 · 40.6 % 26

EPS estimate beaten

Full history 3 of 13 quarters (23%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/19/2026 Neuraxis, INC (NRXS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?